| Literature DB >> 30642262 |
Lahiru Sandaruwan Galgamuwa1, Buthsiri Sumanasena2, Devika Iddawela3, Susiji Wickramasinghe3, Lalani Yatawara4.
Abstract
BACKGROUND: Cytokines play a vital role in the host immune response to infection by initiating the healing process and/or accelerating the progression of the disease in cutaneous leishmaniasis (CL). Very little evidence is available on cytokine profiles and their regulatory function in CL patients in Sri Lanka. The aim of this study was to determine the cytokine expression pattern of IFN-γ, IL-4, IL-11 and IL-12p40 in CL patients and in healthy volunteers. Patients with suspected CL lesions attending to the Dermatology Clinic at the Anuradhapura Teaching Hospital were included in the study. Reverse transcription real time polymerase chain reaction (real-time RT-PCR) was performed to determine the relative expression level of target cytokines. Expression levels were quantified by 2- ∆∆CT equation.Entities:
Keywords: Cutaneous leishmaniasis; IFN-γ; IL-11; IL-12p40; IL-4; Sri Lanka
Mesh:
Substances:
Year: 2019 PMID: 30642262 PMCID: PMC6332851 DOI: 10.1186/s12866-018-1384-4
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Oligonucleotide sequence of primers used for amplification of cytokines
| Cytokine | Oligonucleotides sequence (5′—› 3′) | Fragment size (bp) |
|---|---|---|
| IFN –γ | F: CAG CTC TGC ATC GTT TTG GGT TCT | 466 |
| R: TGC TCT TCG ACC TCG AAA CAG CAT | ||
| IL-11 | F: CACATGAACTGTGTTTGCCGCCTGGT | 295 |
| R: GCAGCCTTGTCAGCACACCTGGGAGCTGTAGA | ||
| IL – 4 | F: GAA CAG CCT CAC AGA GCA GAA GAC | 221 |
| R: TGT CGA GCC GTT TCA GGA ATC | ||
| IL-12p40 | F: CCA AGA ACT TGC AGC TGA AG | 355 |
| R: TGG GTC TAT TCC GTT GTG TC | ||
| GAPDH | F: TGACCTCAACTACATGGTTTA | 151 |
| R: GCCCCACTTGATTTTGGA |
Fig. 1Gelelctrophoresis of nested PCR products of species specific primers of Leishmania donovani. M – molecular marker (100 bp), Lanes 1 to 4 – First PCR products, Lanes 5 to 8 – Second PCR products, Lanes 1 and 5 – Positive control, Lanes 2,4,6 & 8 – Negative controls, Lanes 3 and 7 – Test sample. Expected fragment size for the 1st PCR was 576 bp and 2nd PCR was 378 bp
Basic clinical characteristics of leishmaniasis patients
| Variables | Frequency |
|---|---|
| Sex (male/female) | 33/10 |
| Age, mean (SD) years | 37.8 (12.6) |
| Duration of lesions, mean (SD) months | 10.5 (6.8) |
| No. of lesions, mean (range) | 1.3 (1–3) |
| Size of lesions, mean (range) mm2 | 256.1 (22–1800) |
| Site of lesions | |
| Upper limbs | 20 (46.5%) |
| Lower limbs | 14 (32.6%) |
| Face/Neck | 9 (20.9%) |
| Type of lesions | |
| Papulo-nodular | 15 (34.9%) |
| Nodular-ulcerative | 20 (46.5%) |
| Ulcers | 8 (18.6%) |
| Dry lesions | 32 (74.4%) |
| Wet lesions | 11 (25.6%) |
Fig. 2Correlation graphs of log normalized cytokine expressions in CL patients. x and y values - log10 normalized gene expressions
Correlation coefficients between cytokine gene expression
| Cytokine | IFN-γ | IL-4 | IL-11 | IL-12p40 | |
|---|---|---|---|---|---|
| IFN-γ | Correlation Coefficient | – | 0.564** | 0.451** | 0.598** |
| – | < 0.001 | 0.003 | < 0.001 | ||
| IL-4 | Correlation Coefficient | 0.564** | – | 0.830** | 0.862** |
| < 0.001 | – | < 0.001 | < 0.001 | ||
| IL-11 | Correlation Coefficient | 0.451** | 0.830** | – | 0.847** |
| 0.003 | < 0.001 | – | < 0.001 | ||
| IL-12p40 | Correlation Coefficient | 0.598** | 0.862** | 0.847** | – |
| < 0.001 | < 0.001 | < 0.001 | – |
**Correlation is significant at the 0.01 level
Fig. 3Relative expression levels of cytokine cDNA in CL patients and normal healthy people. Cytokine levels in each group are shown as median and inter quartile range (box) with 5th and 95th percentiles (whiskers)
Fig. 4Relative expression levels of cytokine CDNA in CL patients with different clinical characteristics. The results are shown as mean expression values (±) standard errors
Multiple regression analysis of cytokine gene expressions and clinical and socio demographic parameters
| IFN- γ | IL-4 | IL-11 | IL-12p40 | |||||
|---|---|---|---|---|---|---|---|---|
| β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | |||||
| Constant | 1.518 | 0.091 | 0.362 | 0.111 | 0.915 | 0.817 | 0.937 | 0.201 |
| R sq | 0.338 | 0.326 | 0.133 | 0.286 | ||||
| Gender | −0.001 (−0.026,0.023) | 0.922 | − 0.005 (− 0.025, 0.016) | 0.649 | −0.003 (− 0.029, 0.022) | 0.785 | −0.006 (− 0.027, 0.014) | 0.535 |
| Age | −0.281 (− 0.780,0.219) | 0.261 | −0.003 (− 0.412, 0.405) | 0.988 | −0.133 (− 0.645, 0.378) | 0.600 | −0.065 (− 0.477, 0.348) | 0.752 |
| Duration of lesions | 0.061 (0.016, 0.105) | 0.009 | 0.017 (−0.020, 0.053) | 0.355 | 0.012 (−0.034, 0.058) | 0.595 | 0.034 (−0.003, 0.071) | 0.067 |
| Number of lesions | −0.201 (− 0.712,0.310) | 0.420 | 0.357 (− 0.061, 0.775) | 0.092 | −0.198 (− 0.721, 0.325) | 0.446 | −0.166 (− 0.588, 0.256) | 0.429 |
| Surface area of lesions | 0.001 (0.000,0.003) | 0.107 | −0.001 (− 0.002, 0.000) | 0.143 | − 0.001 (− 0.002, 0.001) | 0.435 | 0.000 (− 0.002, 0.001) | 0.554 |
| Type of lesions | 0.376 (− 0.194, 0.946) | 0.189 | 0.522 (0.056, 0.988) | 0.022 | 0.313 (−0.270, 0.897) | 0.282 | 0.454 (−0.016, 0.925) | 0.058 |
| Site of lesions | −0.137 (− 0.472, 0.198) | 0.410 | − 0.083 (− 0.357, 0.191) | 0.543 | −0.036 (− 0.379, 0.307) | 0.832 | −0.006 (− 0.282, 0.271) | 0.966 |
| Type of lesions | −0.105 (− 0.430, 0.221) | 0.518 | −0.176 (− 0.442, 0.090) | 0.188 | −0.045 (− 0.378, 0.289) | 0.787 | −0.078 (− 0.347, 0.190) | 0.557 |
| Inflammatory signs | −0.129 (− 0.626, 0.367) | 0.600 | −0.017 (− 0.423, 0.389) | 0.934 | −0.007 (− 0.515, 0.502) | 0.979 | −0.165 (− 0.575, 0.245) | 0.420 |
β – Correlation coefficient